Showing results (1581-1590 of 1,670) with videos related to
Sort By:
Pageof 167
Blood|September 22, 2010
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitorsMustafa Daghistani, David Marin, Jamshid Sorouri Khorashad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsDavid Marin, Amr R Ibrahim, Claire Lucas, et al.Leukemia & Lymphoma|November 6, 2012
Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms WorkshopRichard A Van Etten, Michael Mauro, Jerald P Radich, et al.Blood|September 21, 2007
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemiaEduardo Olavarria, Shamyla Siddique, Michael J Griffiths, et al.Haematologica|October 17, 2009
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemiaDragana Milojkovic, Emma Nicholson, Jane F Apperley, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 26, 2011
To share or not to share: a randomized trial of consent for data sharing in genome researchAmy L McGuire, Jill M Oliver, Melody J Slashinski, et al.Journal of Environmental Sciences (China)|August 5, 2017
Method to assess component contribution to toxicity of complex mixtures: Assessment of puberty acquisition in rats exposed to disinfection byproductsShahid Parvez, Glenn E Rice, Linda K Teuschler, et al.Journal of Diabetes Science and Technology|May 9, 2022
The Launch of the iCoDE Standard ProjectNicole Y Xu, Kevin T Nguyen, Ashley Y DuBord, et al.Blood|March 21, 1998
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study GroupR P Gale, R Hehlmann, M J Zhang, et al.Cancer Treatment and Research Communications|May 24, 2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinibDylan J Martini, Meredith R Kline, Yuan Liu, et al.Pageof 167